Dr. Dunleavy is a 55-year-old internal medicine physician. He founded Inovalon, a cloud-based software and healthcare analytics firm.
The company went public in 2015 and was sold to a group of private equity firms in 2021. Dr. Dunleavy owns an estimated 11% of Inovalon.
Dr. Dunleavy continues to serve as Inovalon’s CEO and is a member of the company’s board of directors.
Here is how Dr. Dunleavy’s wealth has changed since 2021:
2021: $1.4 billion
2022: $1.7 billion
2023: $1.7 billion
2024: $1.9 billion
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.